> Agenda
Program Overview
| 09.00 am | Registration & poster exhibition opens. The poster exhibition will be open all day. |
| 10.00 – 10.05 am | Welcome & opening remarks, Dr. Christian Stein, Ascenion GmbH |
| 10.05 – 11.05 am | Presentation stream 1 – Cardiovascular Diseases, Dermatology & Neurological Disorders A2 Inhibition of protein-protein interactions for the development of novel drug candidates for the treatment of cardiovascular diseases,
Leibniz-Institiute for Molecular Pharmacology P2 KERatin, University of Cologne
B1 Protein aggregation inhibitors as disease-modifying drugs for neurodegenerative diseases, LMU
I2 Use of Lornoxicam against Alzheimer´s Disease, IP Bewertungs AG
A1 Peptides for the diagnosis and therapy of Alzheimer’s Disease, Heinrich-Heine-Universität Düsseldorf
M2 Taxol induces axon regeneration, Max-Planck-Institute of Neurobiology |
| 11.05 – 11.35 am | Poster session – Ask the experts |
| 11.35 – 12.35 pm | Presentation stream 2 – Tools, Metabolism, Drug Delivery & Drug Development E1 miQPCR, improved quantification of microRNAs, University Clinic Heidelberg & European Molecular Biology Laboratory, Heidelberg
E2 Cell-based method for analysis of protein-protein interactions, European Molecular Biology Laboratory, Heidelberg
I1 Terahertz biochip technology for high sensitivity label-free DNA sensors, IP Bewertungs AG
P1 FTO Knock-out, Heinrich-Heine-University of Düsseldorf
U6 Novel thermosensitive nanocarriers for drug targeting, University Hospital of Munich, Max Planck Society and Helmholtz Zentrum München
M1 Cellular Target Profiling™: chasing drug actions and side effects, Kinaxo Biotechnologies GmbH |
| 12.35 – 01.05 pm | Poster session – Ask the experts |
| 12.35 – 01.45 pm | Lunch |
| 01.45 – 02.45 pm | Presentation stream 3 – Infection A3 Synthetic antimicrobial and LPS-neutralizing peptides (SALP) for prevention and treatment of sepsis, Research Center Borstel
B2 Bacterial TIR domain mimics as autoimmune and anti-infective therapeutics, Technische Universität München
N1 Expression profiles for the prediction of septic states, Justus-Liebig-University Giessen
U4 An improved vaccine for prophylaxis and treatment of tuberculosis, Vakzine Projektmanagement GmbH
U5 A safe, well tolerated and efficacious vaccine against infection with HCMV, Vakzine Projektmanagement GmbH
G1 Antiadhesive strategies for bacterial infections, University Medical Center Hamburg-Eppendorf
|
| 02.45 – 03.15 pm | Poster session – Ask the experts |
| 03.15 – 04.00 pm | Keynote: Dr. Oliver Weyand, Senior Manager, PricewaterhouseCoopers AG „Pharma 2020 – challenges to the pharma business model and the impact on cooperations“ |
| 04.00 – 05.00 pm | Presentation stream 4 – Oncology & Immunology D1 Redesigned bacterial killers for the treatment of breast cancer and melanoma, DKFZ
D6 Platinum-Xanthates as tumor therapeutics, DKFZ
F2 nONCOchip – a tool for the discovery of non-protein coding RNA biomarkers in oncology, Fraunhofer Institute for Cell Therapy and Immunology
G3
Statins and astemizole block cell proliferation of small cell lung cancer cells in vitro, University Medical Center Hamburg-Eppendorf
U1 Targeted therapies against cancer based on the discovery of a novel tumor specific marker, „heat shock protein 70“ (Hsp70), Multimmune GmbH
F3 Antigen specific tolerance induction: a new method to regulate the immune response specifically,
Fraunhofer Institute for Cell Therapy and Immunology |
| 05.00 – 05.30 pm | Poster session – Ask the experts |
| 06.00 pm | Poster exhibition closes |
Please see the floor plan for your orientation
